chartexchange

PMVP
PMV Pharmaceuticals, Inc
stockNASDAQ

At CloseOct 2, 2026 3:59:48 PM EDT
1.79USD+2.286%(+0.04)3,735,853
Loading…
Loading…
Healthcare
Biotechnology
HQ
Cranbury, NJ, USA
Previous Close
$1.75
Beta
0.63
52-Week High
$1.91 2026-10-01
52-Week Low
$1.02 2026-02-23
SMA 50
$1.32
SMA 200
$1.28
Avg. Vol 10D
1.14M
Avg. Vol 30D
975,787
Avg. Vol 90D
536,592
Relative Vol
3.83
48.90M
1.8700%
5,400,000
4,474
Nov 11, 2026 (37d)
PMVP Profile

pmv pharmaceuticals, inc., a precision oncology company, discovery and development of small molecule, tumor-agnostic therapies for p53 mutations in cancer. its lead product candidate is pc14586, a small molecule that corrects and restores p53 function. the company also develops product candidates for p53 r273h hotspot mutation and other p53 hotspot mutations. pmv pharmaceuticals, inc. was formerly known as pj pharmaceuticals, inc. and changed to in july 2013. the company was founded in 2013 and is headquartered in cranbury, new jersey.

PMVP Performance
PeriodPriceDateChangeBeta
1W1.362026-09-28+31.25%-9.711
1M1.292026-09-04+38.37%-0.874
3M1.212026-07-06+48.13%-0.106
6M1.302026-04-06+37.31%0.256
1Y1.442025-10-03+23.96%0.625
2Y1.532024-10-04+16.67%—
5Y28.882021-10-04-93.82%1.131
PMVP Stock Summary

PMV Pharmaceuticals, Inc (NASDAQ:PMVP) stock price today is $1.79, and today's volume is 3,735,853. PMVP is up 2.000% today. The 30 day average volume is 975,787. PMVP market cap is $95.42M with 53.46M shares outstanding.